Liver Resection for Hepatic Metastases from Soft Tissue Sarcoma: A Nationwide Study

Autor: Iris D. Nagtegaal, Frederike A B Grimme, Koert P. de Jong, Cornelis Verhoef, Richard van Hillegersberg, M F J Seesing, Johannes H. W. de Wilt, Frits van Coevorden
Přispěvatelé: Surgery, Groningen Institute for Organ Transplantation (GIOT), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
Rok vydání: 2019
Předmět:
Leiomyosarcoma
Male
Neoplasm
Residual

Colorectal cancer
Soft Tissue Neoplasms
Kaplan-Meier Estimate
DISEASE
COLORECTAL-CANCER
Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14]
Postoperative Complications
0302 clinical medicine
PROGNOSTIC-FACTORS
Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14]
Liver metastasis
Netherlands
Aged
80 and over

Liver resection
Soft tissue sarcoma
Liver Neoplasms
Gastroenterology
Sarcoma
Middle Aged
Progression-Free Survival
SINGLE-CENTER EXPERIENCE
Survival Rate
medicine.anatomical_structure
030220 oncology & carcinogenesis
Female
030211 gastroenterology & hepatology
Adult
medicine.medical_specialty
Resection
03 medical and health sciences
All institutes and research themes of the Radboud University Medical Center
medicine
MANAGEMENT
Hepatectomy
Humans
Survival analysis
Aged
Retrospective Studies
R0 resection
Original Paper
business.industry
medicine.disease
Hepatic resection
Surgery
Feasibility Studies
Abdomen
business
Zdroj: Digestive Surgery, 36, 6, pp. 479-486
Digestive Surgery, 36, 479-486
Digestive Surgery, 36(6), 479-486. Karger
Digestive Surgery, 36(6), 479-486. KARGER
Digestive Surgery, 36(6), 479. S. Karger AG
ISSN: 0253-4886
Popis: Background: This study aims to evaluate the feasibility and safety of resection of sarcoma liver metastases, and to identify possible prognostic factors for long-term survival. Methods: All patients who underwent resection of liver metastases of sarcoma in the Netherlands from 1998 to 2014 were included. Study data was retrospectively collected from patient files. Survival rates were calculated using Kaplan-Meier survival analysis. Results: Some 38 patients treated in 16 hospitals were included (15 male, 23 female). The median age was 57 years (37–80 years). The most common histological subtype was leiomyosarcoma (63%). The predominant site of primary tumour was the abdomen (59%). R0 resection was achieved in 16 patients. Mortality was 3 and 16% of included patients had 1 or more complications. The median follow-up period was 18 months (range 1–161). After liver resection, 1-, 3-, and 5-year survival were 88, 54, and 42% respectively. Median overall survival was 46 months (1–161 months). One- and three-year progression-free survival (PFS) after liver resection were 54 and 19% respectively. Median PFS was 16 months (1–61 months). Conclusions: Liver surgery for sarcoma metastases is safe and leads to a relatively good survival. The choice for surgical treatment should always be discussed in a multidisciplinary sarcoma and liver team.
Databáze: OpenAIRE